등록된 논문 166건

※ 클릭시 해당 논문페이지로 이동합니다.

• KCSG GU11-05비뇨기/부인암

  Phase II Study of Dovitinib in Patients with Castration-Resistant Prostate Cancer (KCSG-GU11-05).

  • 저널 Cancer Res Treat. 2018 Oct;50(4):1252-1259.
  • 제1저자 최윤지
  • 교신저자 박경화

• KCSG ST14-11위암

  Phase II study of oxaliplatin, irinotecan and S-1 therapy in patients with advanced gastric cancer: the Korean Cancer Study Group ST14-11

  • 저널 Gastric Cancer. 2018 Sep;21(5):802-810.
  • 제1저자 김형수, 류민희
  • 교신저자 장대영

• KCSG BR13-11유방암

  Phase II, multicentre, randomised trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy in patients with HER2-negative metastatic breast cancer

  • 저널 Eur J Cancer. 2017 Nov;86:385-393.
  • 제1저자 박연희
  • 교신저자 정경해

• KCSG LY16-01림프종

  Multicenter Retrospective Analysis of Clinical Characteristics, Treatment Patterns, and Outcomes in Very Elderly Patients with Diffuse Large B-Cell Lymphoma: The Korean Cancer Study Group LY16-01

  • 저널 Cancer Res Treat . 2018 Apr;50(2):590-598.
  • 제1저자 최정혜
  • 교신저자 최정혜

• KCSG LU13-08폐암

  Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non-Small-Cell Lung Cancer Harboring ROS1 Rearrangement.

  • 저널 J Clin Oncol. 2017 Aug 10;35(23):2613-2618
  • 제1저자 임선민, 김혜련
  • 교신저자 안명주, 조병철

• KCSG GU14-08비뇨기/부인암

  Efficacy and Toxicity of Mammalian Target Rapamycin Inhibitors in Patients with Metastatic Renal Cell Carcinoma with Renal Insufficiency: The Korean Cancer Study Group GU 14-08

  • 저널 Cancer Res Treat. 2016 Oct;48(4):1286-1292.
  • 제1저자 김기향
  • 교신저자 라선영

• KCSG LU05-04폐암

  Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non-Small-Cell Lung Cancer: KCSG-LU05-04.

  • 저널 J Clin Oncol. 2015 Aug 20;33(24):2660-6.
  • 제1저자 안진석
  • 교신저자 박근칠

• KCSG 0806폐암

  A multicenter phase II study of sorafenib in combination with erlotinib in patients with advanced non-small cell lung cancer (KCSG-0806).

  • 저널 Lung Cancer. 2016 Mar;93:1-8.
  • 제1저자 임선민
  • 교신저자 김주항

• KCSG PC10-09완화의료

  A randomized, multicenter, phase II/III study to determine the optimal dose and to evaluate the efficacy and safety of pegteograstim (GCPGC) on chemotherapy-induced neutropenia compared to pegfilgrastim in breast cancer patients: KCSG PC10-09.

  • 저널 Support Care Cancer. 2016 Apr;24(4):1709-17
  • 제1저자 이기형
  • 교신저자 오도연, 임석아

• KCSG HN14-01두경부암

  Clinical Trial of Nintedanib in Patients with Recurrent or Metastatic Salivary Gland Cancer of the Head and Neck:A Multicenter Phase 2 Study (Korean Cancer Study Group HN14-01)

  • 저널 Cancer. 2017 Jun 1;123(11):1958-1964.
  • 제1저자 김유진
  • 교신저자 안명주

1112131415